Showing 181-190 of 2745 results for "".
MATV News: Revance’s Daxxify Approved; ASPS Data Show Cosmetic Surgery Booming; DREAM Initiative Supports Residency Curriculum for Advancing Racial Equity
https://modernaesthetics.com/series/matv-news/matv-news-revances-daxxify-approved-asps-data-show-cosmetic-surgery-booming-dream-initiative-supports-residency-curriculum-for-advancing-racial-equity/33703/Revance Therapeutics’ Daxxify (daxibotulinumtoxinA-lanm) wins FDA approval for the temporary improvement of moderate to severe glabellar lines in adults. Clinical trial investigator Jeffrey Dover, MD discusses Daxxify’s unique Peptide Exchange Technology (PXT) and long-lasting effects. New data fromMATV News: Juvéderm Volux XC Approved; Joe Jonas and Xeomin Partner; Breast Implants Recipients Not Following Screening Guidelines
https://modernaesthetics.com/series/matv-news/matv-news-juvederm-volux-xc-approved-joe-jonas-and-xeomin-partner-breast-implants-recipients-not-following-screening-guidelines/33701/Allergan Aesthetics wins FDA approval for Juvéderm Volux XC for the improvement of jawline definition in adults with moderate to severe loss of jawline definition; Pop icon Joe Jonas is the new brand partner for Merz Aesthetics’ Xeomin; and a new study finds silicone breast implant recipients may noAccuracy of Online Estimates: An Update
https://modernaesthetics.com/ma-issues-index/2022-july-aug/accuracy-of-online-estimates-an-update/35189/Slight discrepancies between online estimates and actual procedure costs do not have a significant impact on patients’ decision to undergo treatments.Scientific Advancements Leading to New Options to Manage Aesthetic Concerns
https://modernaesthetics.com/ma-issues-index/2022-july-aug/scientific-advancements-leading-to-new-options-to-manage-aesthetic-concerns/35185/Updates on some of the latest developments in minimially invasive aesthetics.MATV News: Promising Data for Galderma's RelabotulinumtoxinA; FDA Approves Sientra's New Breast Implant; Allergan Aesthetics Shares Global Trends Report
https://modernaesthetics.com/series/matv-news/matv-news-promising-data-for-galdermas-relabotulinumtoxina-fda-approves-sientras-new-breast-implant-allergan-aesthetics-shares-global-trends-report/33697/Galderma's investigational RelabotulinumtoxinA, a novel liquid formulation botulinum toxin A, improves glabellar and lateral canthal lines with a rapid onset of action and a long duration up to six months, according to top-line Phase 3 data; and Sientra wins FDA approval for its Low Plus Profile ProNot the Average Investor
https://modernaesthetics.com/ma-issues-index/2022-may-june/not-the-average-investor/35173/Why physicians need a different approach to investing.MATV News: Dr. Jennifer Walden is First Female President of The Aesthetic Society; Plastic Surgeon Residents Face Childcare Issues; ASLMS President Outlines Goals
https://modernaesthetics.com/series/matv-news/matv-news-dr-jennifer-walden-is-first-female-president-of-the-aesthetic-society-plastic-surgeon-residents-face-childcare-issues-aslms-president-outlines-goals/33685/Jennifer Walden, MD discusses her role and goals as the first female president of the Aesthetic Society; a new survey study finds plastic surgeon residents, especially women, face barriers accessing affordable childcare; and Paul Friedman, MD shares plans for his ASLMS presidency, including creatingMATV News Extra: The Lowdown on Allergan Alle Flash
https://modernaesthetics.com/series/matv-news/matv-news-extra-the-lowdown-on-allergan-alle-flash/33682/Jasson Gilmore, Co-Founder of Allergan Data Labs, discusses the evolution of Allergan's Alle loyalty program and the launch of the Alle Flash. He shares insights on the benefits for patients and providers.MATV News: AIS Meeting Highlights; Benefits of Allergan Aesthetics’ Loyalty Program; A Lack of Diversity in Aesthetic Clinical Trials
https://modernaesthetics.com/series/matv-news/matv-news-ais-meeting-highlights-benefits-of-allergan-aesthetics-loyalty-program-a-lack-of-diversity-in-aesthetic-clinical-trials/33671/Physician and industry experts share highlights from the Aesthetics Innovation Summit; Allergan Aesthetics enhances its loyalty program with the launch of Alle Flash; and a new study shows a lack of ethnic/racial diversity in industry-sponsored aesthetic trials.Five Strategies to Attract the Right Clientele
https://modernaesthetics.com/ma-issues-index/2022-mar-apr/five-strategies-to-attract-the-right-clientele/35153/Tips for bringing attention to your aesthetics practice.